Selected research
Industry Research
Preclinical Research Service Industry Research Report 2026
Market perspective
The global Preclinical Research Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Preclinical Research Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Preclinical Research Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Preclinical Research Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Preclinical Research Service include Altasciences, VIMTA, Precision Medicine, NAMSA, Charles River, Medicilon, Oncodesign Services, Veranex and Jubilant Biosys, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Preclinical Research Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Preclinical Research Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Preclinical Research Service Market by Company
Altasciences
VIMTA
Precision Medicine
NAMSA
Charles River
Medicilon
Oncodesign Services
Veranex
Jubilant Biosys
IDEXX Laboratories
BioTrial
VIRTUS
Cynbiose
LifeTec
AmplifyBio
Certis
Noble Life Sciences
Veeda
QPS
Preclinical Research Service Segment by Type
Non GLP Safety Assessment
GLP Safety Assessment
Preclinical Research Service Segment by Application
Virology
Immunology
Molecular Biology
Pathology
Others
Preclinical Research Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preclinical Research Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Preclinical Research Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preclinical Research Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Preclinical Research Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Non GLP Safety Assessment
- GLP Safety Assessment
Applications
- Virology
- Immunology
- Molecular Biology
- Pathology
- Others
Companies covered
- Altasciences
- VIMTA
- Precision Medicine
- NAMSA
- Charles River
- Medicilon
- Oncodesign Services
- Veranex
- Jubilant Biosys
- IDEXX Laboratories
- BioTrial
- VIRTUS
- Cynbiose
- LifeTec
- AmplifyBio
- Certis
- Noble Life Sciences
- Veeda
- QPS
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Preclinical Research Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Non GLP Safety Assessment
- 2.2.3 GLP Safety Assessment
- 2.3 Preclinical Research Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Virology
- 2.3.3 Immunology
- 2.3.4 Molecular Biology
- 2.3.5 Pathology
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Preclinical Research Service Breakdown Data by Type
- 3.1 Global Preclinical Research Service Historic Market Size by Type (2021-2026)
- 3.2 Global Preclinical Research Service Forecasted Market Size by Type (2027-2032)
4 Preclinical Research Service Breakdown Data by Application
- 4.1 Global Preclinical Research Service Historic Market Size by Application (2021-2026)
- 4.2 Global Preclinical Research Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Preclinical Research Service Market Perspective (2021-2032)
- 5.2 Global Preclinical Research Service Growth Trends by Region
- 5.2.1 Global Preclinical Research Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Preclinical Research Service Historic Market Size by Region (2021-2026)
- 5.2.3 Preclinical Research Service Forecasted Market Size by Region (2027-2032)
- 5.3 Preclinical Research Service Market Dynamics
- 5.3.1 Preclinical Research Service Industry Trends
- 5.3.2 Preclinical Research Service Market Drivers
- 5.3.3 Preclinical Research Service Market Challenges
- 5.3.4 Preclinical Research Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Preclinical Research Service Players by Revenue
- 6.1.1 Global Top Preclinical Research Service Players by Revenue (2021-2026)
- 6.1.2 Global Preclinical Research Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Preclinical Research Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Preclinical Research Service Head Office and Area Served
- 6.4 Global Preclinical Research Service Players, Product Type & Application
- 6.5 Global Preclinical Research Service Manufacturers Established Date
- 6.6 Global Preclinical Research Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Preclinical Research Service Market Size (2021-2032)
- 7.2 North America Preclinical Research Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Preclinical Research Service Market Size by Country (2021-2026)
- 7.4 North America Preclinical Research Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Preclinical Research Service Market Size (2021-2032)
- 8.2 Europe Preclinical Research Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Preclinical Research Service Market Size by Country (2021-2026)
- 8.4 Europe Preclinical Research Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Preclinical Research Service Market Size (2021-2032)
- 9.2 Asia-Pacific Preclinical Research Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Preclinical Research Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Preclinical Research Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Preclinical Research Service Market Size (2021-2032)
- 10.2 South America Preclinical Research Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Preclinical Research Service Market Size by Country (2021-2026)
- 10.4 South America Preclinical Research Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Preclinical Research Service Market Size (2021-2032)
- 11.2 Middle East & Africa Preclinical Research Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Preclinical Research Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Preclinical Research Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Altasciences
- 12.1.1 Altasciences Company Information
- 12.1.2 Altasciences Business Overview
- 12.1.3 Altasciences Revenue in Preclinical Research Service Business (2021-2026)
- 12.1.4 Altasciences Preclinical Research Service Product Portfolio
- 12.1.5 Altasciences Recent Developments
- 12.2 VIMTA
- 12.2.1 VIMTA Company Information
- 12.2.2 VIMTA Business Overview
- 12.2.3 VIMTA Revenue in Preclinical Research Service Business (2021-2026)
- 12.2.4 VIMTA Preclinical Research Service Product Portfolio
- 12.2.5 VIMTA Recent Developments
- 12.3 Precision Medicine
- 12.3.1 Precision Medicine Company Information
- 12.3.2 Precision Medicine Business Overview
- 12.3.3 Precision Medicine Revenue in Preclinical Research Service Business (2021-2026)
- 12.3.4 Precision Medicine Preclinical Research Service Product Portfolio
- 12.3.5 Precision Medicine Recent Developments
- 12.4 NAMSA
- 12.4.1 NAMSA Company Information
- 12.4.2 NAMSA Business Overview
- 12.4.3 NAMSA Revenue in Preclinical Research Service Business (2021-2026)
- 12.4.4 NAMSA Preclinical Research Service Product Portfolio
- 12.4.5 NAMSA Recent Developments
- 12.5 Charles River
- 12.5.1 Charles River Company Information
- 12.5.2 Charles River Business Overview
- 12.5.3 Charles River Revenue in Preclinical Research Service Business (2021-2026)
- 12.5.4 Charles River Preclinical Research Service Product Portfolio
- 12.5.5 Charles River Recent Developments
- 12.6 Medicilon
- 12.6.1 Medicilon Company Information
- 12.6.2 Medicilon Business Overview
- 12.6.3 Medicilon Revenue in Preclinical Research Service Business (2021-2026)
- 12.6.4 Medicilon Preclinical Research Service Product Portfolio
- 12.6.5 Medicilon Recent Developments
- 12.7 Oncodesign Services
- 12.7.1 Oncodesign Services Company Information
- 12.7.2 Oncodesign Services Business Overview
- 12.7.3 Oncodesign Services Revenue in Preclinical Research Service Business (2021-2026)
- 12.7.4 Oncodesign Services Preclinical Research Service Product Portfolio
- 12.7.5 Oncodesign Services Recent Developments
- 12.8 Veranex
- 12.8.1 Veranex Company Information
- 12.8.2 Veranex Business Overview
- 12.8.3 Veranex Revenue in Preclinical Research Service Business (2021-2026)
- 12.8.4 Veranex Preclinical Research Service Product Portfolio
- 12.8.5 Veranex Recent Developments
- 12.9 Jubilant Biosys
- 12.9.1 Jubilant Biosys Company Information
- 12.9.2 Jubilant Biosys Business Overview
- 12.9.3 Jubilant Biosys Revenue in Preclinical Research Service Business (2021-2026)
- 12.9.4 Jubilant Biosys Preclinical Research Service Product Portfolio
- 12.9.5 Jubilant Biosys Recent Developments
- 12.10 IDEXX Laboratories
- 12.10.1 IDEXX Laboratories Company Information
- 12.10.2 IDEXX Laboratories Business Overview
- 12.10.3 IDEXX Laboratories Revenue in Preclinical Research Service Business (2021-2026)
- 12.10.4 IDEXX Laboratories Preclinical Research Service Product Portfolio
- 12.10.5 IDEXX Laboratories Recent Developments
- 12.11 BioTrial
- 12.11.1 BioTrial Company Information
- 12.11.2 BioTrial Business Overview
- 12.11.3 BioTrial Revenue in Preclinical Research Service Business (2021-2026)
- 12.11.4 BioTrial Preclinical Research Service Product Portfolio
- 12.11.5 BioTrial Recent Developments
- 12.12 VIRTUS
- 12.12.1 VIRTUS Company Information
- 12.12.2 VIRTUS Business Overview
- 12.12.3 VIRTUS Revenue in Preclinical Research Service Business (2021-2026)
- 12.12.4 VIRTUS Preclinical Research Service Product Portfolio
- 12.12.5 VIRTUS Recent Developments
- 12.13 Cynbiose
- 12.13.1 Cynbiose Company Information
- 12.13.2 Cynbiose Business Overview
- 12.13.3 Cynbiose Revenue in Preclinical Research Service Business (2021-2026)
- 12.13.4 Cynbiose Preclinical Research Service Product Portfolio
- 12.13.5 Cynbiose Recent Developments
- 12.14 LifeTec
- 12.14.1 LifeTec Company Information
- 12.14.2 LifeTec Business Overview
- 12.14.3 LifeTec Revenue in Preclinical Research Service Business (2021-2026)
- 12.14.4 LifeTec Preclinical Research Service Product Portfolio
- 12.14.5 LifeTec Recent Developments
- 12.15 AmplifyBio
- 12.15.1 AmplifyBio Company Information
- 12.15.2 AmplifyBio Business Overview
- 12.15.3 AmplifyBio Revenue in Preclinical Research Service Business (2021-2026)
- 12.15.4 AmplifyBio Preclinical Research Service Product Portfolio
- 12.15.5 AmplifyBio Recent Developments
- 12.16 Certis
- 12.16.1 Certis Company Information
- 12.16.2 Certis Business Overview
- 12.16.3 Certis Revenue in Preclinical Research Service Business (2021-2026)
- 12.16.4 Certis Preclinical Research Service Product Portfolio
- 12.16.5 Certis Recent Developments
- 12.17 Noble Life Sciences
- 12.17.1 Noble Life Sciences Company Information
- 12.17.2 Noble Life Sciences Business Overview
- 12.17.3 Noble Life Sciences Revenue in Preclinical Research Service Business (2021-2026)
- 12.17.4 Noble Life Sciences Preclinical Research Service Product Portfolio
- 12.17.5 Noble Life Sciences Recent Developments
- 12.18 Veeda
- 12.18.1 Veeda Company Information
- 12.18.2 Veeda Business Overview
- 12.18.3 Veeda Revenue in Preclinical Research Service Business (2021-2026)
- 12.18.4 Veeda Preclinical Research Service Product Portfolio
- 12.18.5 Veeda Recent Developments
- 12.19 QPS
- 12.19.1 QPS Company Information
- 12.19.2 QPS Business Overview
- 12.19.3 QPS Revenue in Preclinical Research Service Business (2021-2026)
- 12.19.4 QPS Preclinical Research Service Product Portfolio
- 12.19.5 QPS Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst